Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Future Medicinal Chemistry is Scopus-indexed (Q3, CiteScore 4.4), WoS SCIE. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1756-8919Verify ISSN ↗1756-8927Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 170 / 328 | 48th | Q3 |
| Drug Discovery | 91 / 161 | 43rd | Q3 |
| Molecular Medicine | 120 / 179 | 33rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q3, CiteScore 4.4.
Future Medicinal Chemistry is Q3 in Pharmacology (rank 170 of 328), Q3 in Drug Discovery (rank 91 of 161) and Q3 in Molecular Medicine (rank 120 of 179), by CiteScore 2025.
Future Medicinal Chemistry is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.4, which places it in quartile Q3 at the 48th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.429, quartile Q3, with an H-index of 106.
Future Medicinal Chemistry is published by Taylor and Francis Ltd. Its print ISSN is 1756-8919 and its online ISSN is 1756-8927.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Future Medicinal Chemistry has an h-index of 111 and a 2-year mean of 3.55 citations per paper (OpenAlex). Its Scopus CiteScore is 4.4, quartile Q3. On 2-year citations it ranks #91 of 319 Scopus journals in Pharmacology.
Future Medicinal Chemistry published 220 papers in 2025; its busiest recent year was 2019 with 233. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from India (36.8%), Saudi Arabia (10.5%) and Egypt (9.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.